Sunday, March 3, 2024
HomeTagsPremarketing Approval

Premarketing Approval

AnchorDx Enrolls the First Patient For Its UriFind® Bladder Cancer Assay Clinical Trial in the U.S.

AnchorDx, a world-leading developer of cancer early detection solutions, announced the first patient enrollment for the UriFind® bladder cancer assay clinical trial in the U.S.,...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics